[1]
Barreto Ribeiro dos Santos, J., Oliveira Lyrio, A., Ferré, F., Pires Mega, T., de Freitas Lopes, A.C. e Fontes Schluckebier Bonan, L. 2025. Post incorporation monitoring into the Brazilian Public Health System: an analysis of Infliximab, Vedolizumab and Tofacitinib for the treatment of ulcerative retocolitis. JORNAL DE ASSISTÊNCIA FARMACÊUTICA E FARMACOECONOMIA. 9, 1 (nov. 2025). DOI:https://doi.org/10.22563/2525-7323.2024.v9.n.1.p.44-57e.